Marksans Pharma Limited has informed the Exchange regarding a press release dated August 21, 2024, titled "Marksans Pharma Limited s wholly owned subsidiary Relonchem Limited receives Marketing Authorization for its products".
Marksans Pharma Limited has informed the Exchange regarding a press release dated August 21, 2024, titled "Marksans Pharma Limited s wholly owned subsidiary Relonchem Limited receives Marketing Authorization for its products".